Effects of Jiedu Huayu Decoction on Th17/Treg Cells and its Cytokines on Patients with Active Ulcerative Colitis

李丹丹,袁星星,杨磊,王炳予,刘长发,张雅丽
DOI: https://doi.org/10.3969/j.issn.1004-745X.2018.01.005
2018-01-01
Abstract:Objective:To observe the clinical efficacy of Jiedu Huayu Decoction on patients with active ulcerative colitis and its effect on Th17/Treg cells and related cytokines.Methods:48 patients with active ulcerative colitis of accumulated damp-heat type were divided into the treatment group(24 cases) and the control group(24 cases) according to random number table.The control group was treated with Mesalazin enteric-coated tablets and the treatment group was treated with Mesalazin enteric-coated tablets combined with Jiedu Huayu Decoction.The course of treatment was 12 weeks in both groups.The clinical efficacy were observed;ELISA method was used to detect the levels of plasma IL-17,IL-10 and TGF-β.Real-Time PCR was used to detect the expression of nuclear transcription factor RORγt/Foxp3 mRNA in Th17/Treg cells.Results:The total effective rate of the treatment group was 91.67%,significantly better than that of the control group (P< 0.05);IL-17 was reduced significantly after treatment compared with before treatment in both groups (P< 0.01) and IL-10 and TGF-β were increased significantly after treatment compared with before treatment in both groups (P<0.01).After treatment,the treatment group was obviously better than the control group(P< 0.01).RORγt mRNA and RORγt/Foxp3 ratio was reduced significantly after treatment compared with before treatment in both groups(P<0.01) and Foxp3 mRNA was increased significantly after treatment compared with before treatment in both groups.(P < 0.01).After treatment,the treatment group was obviously better than the control group (P< 0.05 or P< 0.01).Conclusion:Jiedu Huayu Decoction can obviously improve the clinical symptoms of patients with active ulcerative colitis of accumulated damp-heat type,decrease IL-17,increase levels of IL-10 and TGF-β,regulate the expression of RORγt and Foxp3 mRNA,and promote the balance of Th17/Treg cells,with a low recurrence rate and obvious curative effect.
What problem does this paper attempt to address?